Related Experiment Video

Updated: Aug 12, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.5K

The heart: pathophysiology and clinical implications of cirrhotic cardiomyopathy

Ying-Ying Yang1, Han-Chieh Lin

  • 1Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC. yangyy@vghtpe.gov.tw

Journal of the Chinese Medical Association : JCMA
|December 19, 2012
PubMed

Insights

Cirrhosis causes hyperdynamic circulation and cardiac dysfunction, known as cirrhotic cardiomyopathy. Understanding the underlying mechanisms is crucial for developing effective treatments for this complex condition.

Area of Science:

  • Gastroenterology and Hepatology
  • Cardiology
  • Internal Medicine

Background:

  • Cirrhosis is characterized by a hyperdynamic circulatory state, including peripheral vasodilation and elevated cardiac output.
  • Peripheral vasodilation is a key factor in both hyperdynamic circulation and portal hypertension in cirrhosis.
  • The precise mechanisms driving hyperdynamic circulation in cirrhosis are not fully understood, with previous research focusing on humoral factors.

Purpose of the Study:

  • To explore the underlying mechanisms of hyperdynamic circulation in cirrhosis.
  • To differentiate cirrhotic cardiomyopathy (CCM) from other cardiac conditions.
  • To highlight the clinical presentation and management challenges of CCM.

Main Methods:

  • Review of existing literature on humoral factors (e.g., nitric oxide, endotoxin) implicated in cirrhosis.
  • Clinical observation of patients with cirrhosis and associated cardiac dysfunction.
  • Analysis of clinical presentations including sodium/fluid retention and latent heart failure.

Main Results:

  • Humoral factors like nitric oxide and endotoxin are suspected mediators of hyperdynamic circulation in cirrhosis.
  • Cirrhotic cardiomyopathy (CCM) presents as a distinct cardiac dysfunction in cirrhotic patients.
  • Patients often exhibit sodium and fluid retention, with latent heart failure unmasked by physiological stress.

Conclusions:

  • The mechanisms of hyperdynamic circulation in cirrhosis require further investigation.
  • Cirrhotic cardiomyopathy is a significant clinical entity in liver disease patients.
  • Current treatment options for CCM are limited, necessitating further research into prevalence, impact, and therapeutic strategies.

More Related Videos

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.4K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...